Persistent capital consumption is evident, with quarterly free cash flow deficits frequently exceeding $1.5M and an OCF/NI ratio often near 1.00, indicating a pure cash burn.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Cash from Operations | -5.72M | -5.7M | -3.97M | -6.73M | -8.08M | -11.28M | -6.57M | -5.78M | -4.41M | -2.61M | -6.04M | -802.67K | -6.2M | 5.1M | 365.17K | 790.51K | -7.82M | -5.92M | -128.49K |
| Operating CF Margin % | - | -462.73% | -113.72% | -232.05% | -275.87% | -469.12% | -410.41% | -344% | -340.2% | -343.64% | -1017.97% | -254.24% | -49.51% | 29.74% | 2.34% | 5.14% | -49.2% | -35.34% | -60.82% |
| Operating CF Growth % | -882.81% | -43.46% | 40.91% | 16.79% | 28.32% | -71.53% | -13.69% | -31.21% | -69.1% | 56.82% | -651.91% | 87.05% | -221.67% | 1295.47% | -53.81% | 110.12% | -32.08% | -4504.98% | - |
| Net Income | -7.29M | -7.36M | -5.81M | -6.8M | -9.74M | -13.07M | -9.33M | -8.31M | -5.69M | -2.14M | -3.61M | 65.79M | -5.98M | -428.05K | 1.35M | -10.88M | -10.51M | -6.08M | -190.78K |
| Depreciation & Amortization | 12.35K | -24.17K | 0 | 0 | 0 | 0 | 0 | 0 | 676.64K | 0 | 0 | 0 | 271.13K | 253.5K | 256.48K | 250.18K | 602.73K | 586.69K | 0 |
| Stock-Based Compensation | 705.15K | 930.18K | 1.13M | 1.24M | 1.89M | 1.78M | 1.65M | 0 | 467.2K | 643.43K | 624.81K | 1.11M | 984.16K | 806.56K | 1.2M | 0 | 1.6B | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -676.64K | 0 | 0 | 0 | -890.13K | -725.56K | 0 | 0 | -1.6B | 0 | 0 |
| Other Non-Cash Items | 183.95K | 95.6K | -46.45K | -1.03M | 83.71K | -1.18M | 108.91K | 1.4M | 697.42K | -273.09K | -359.59K | -69.27M | 1.01M | 725.56K | -1.24M | 1.89M | 758.33K | 923.91K | 0 |
| Working Capital Changes | 674.46K | 660.79K | 754.53K | -143.21K | -321.17K | 1.19M | 990.08K | 1.13M | 119.94K | -840.78K | -2.69M | 1.57M | -1.59M | 4.46M | -3.04M | 9.53M | 1.34M | -1.35M | 62.29K |
| Change in Receivables | -762.08K | -857.85K | 205.26K | -93.13K | -47.17K | -13.92K | 1.08M | 218.62K | -59.98K | 333.02K | -513.47K | -78.95K | 602.27K | -36.03K | -3.31M | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234.68K | -1.21M | -1.96M | 1.44M | -830.75K | 46.1K | 266.19K | -625.52K | 1.23M | -2.09M | 0 |
| Change in Payables | 579.73K | 314.45K | -180.18K | -651.17K | -248.13K | 549.56K | -53.2K | 657.66K | -195.75K | 207.43K | -339.74K | 134.25K | -1.01M | 885.93K | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 866.18K | 82.08K | -1.88M | 7.45M | -2.37M | 5.22M | 22.12M | 7.71M | 3.33M | 103K | -42.56M | 66.83M | -252.61K | -414.09K | -103.94K | -859.58K | -447.95K | -101.38K | 7.12K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -350.29K | -406.07K | -45.81K | -519.47K | -413.29K | -101.38K | 0 |
| CapEx % of Revenue | 0% | - | 0% | - | - | - | 0% | 0% | - | - | - | - | 2.8% | 2.37% | 0.29% | 3.38% | 2.6% | 0.61% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67M | 0 | 0 | 0 | -375K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.33M | -812.08K | -42.56M | -165.52K | 97.67K | -8.02K | -58.12K | 34.89K | -34.66K | 0 | 7.12K |
| Cash from Financing | 4.94M | 4.96M | 5.85M | 0 | 543.59K | 1.23M | 255.47K | 550.19K | -2.3M | -6.22M | -13.12M | 73.88K | 55.74K | 220.57K | 37.07K | 18.99M | -97.76K | 24.88M | 0 |
| Debt Issued (Net) | 0 | 0 | 5.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.94K | 0 | 0 | 0 | 0 | 0 | -1.01M | 0 |
| Equity Issued (Net) | 4.94M | 4.96M | 24.25K | 0 | 0 | 0 | 255.47K | 550.19K | -2.3M | -6.22M | -13.19M | 8.07K | 55.74K | 61.38K | 37.07K | 13.44M | 0 | 27.39M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.3M | -6.22M | -13.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 543.59K | 1.23M | 0 | 0 | 4.5K | 1.44K | 66.13K | 90.75K | 0 | 159.19K | 0 | 5.55M | -97.76K | -1.5M | 0 |
| Net Change in Cash | 335.93K | -653.25K | -8.28K | 720.76K | -9.95M | -4.89M | 15.81M | 2.44M | -3.4M | -8.47M | -61.71M | 66.11M | -6.4M | 4.9M | 298.31K | 18.92M | -8.36M | 18.86M | -121.37K |
| Free Cash Flow | -5.72M | -5.7M | -3.97M | -6.73M | -8.08M | -11.28M | -6.57M | -5.78M | -4.41M | -2.61M | -6.04M | -802.67K | -6.55M | 4.69M | 319.36K | 271.04K | -8.23M | -6.02M | -128.49K |
| FCF Margin % | -192.15% | -462.73% | -113.72% | -232.05% | -275.87% | -469.12% | -410.41% | -344% | -340.2% | -343.64% | -1017.97% | -254.24% | -52.3% | 27.37% | 2.05% | 1.76% | -51.81% | -35.95% | -60.82% |
| FCF Growth % | -18.79% | -43.46% | 40.91% | 16.79% | 28.32% | -71.53% | -13.69% | -31.21% | -69.1% | 56.82% | -651.91% | 87.75% | -239.67% | 1368.51% | 17.83% | 103.29% | -36.72% | -4583.88% | - |
| FCF per Share | -0.16 | -0.17 | -0.14 | -0.23 | -0.28 | -0.41 | -0.24 | -0.21 | -0.16 | -0.09 | -0.17 | -0.02 | -0.19 | 0.14 | 0.01 | 0.01 | -0.37 | -0.37 | -0.03 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.77x | 0.68x | 0.99x | 0.83x | 0.86x | 0.71x | 0.70x | 0.77x | 1.22x | 1.67x | -0.01x | 1.04x | -11.90x | 0.27x | -0.07x | 0.74x | 0.97x | 0.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 909 | 835.21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.5K | 1.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Limited operational cash runway
Based on the provided quarterly cash flow statements, the company's operating cash flow consistently mirrors net losses, with OCF/NI ratios frequently approaching 1.00, which suggests that the reported net income is not being distorted by significant non-cash accruals but rather reflects a pure cash burn.
The tight correlation between net income and operating cash flow indicates that the company lacks meaningful non-cash expenses to buffer its bottom line. This suggests that the reported losses are essentially cash-based, leaving little room for operational efficiency improvements without a fundamental change in the revenue model.
As reported in financial statements, the company has maintained a negative free cash flow trajectory across all observed periods, with quarterly outflows frequently exceeding $1.5M, indicating that the business remains in a state of sustained capital consumption without any clear path to self-funding operations.
The absence of positive free cash flow suggests that the company's R&D-heavy business model is currently unable to generate sufficient returns to cover its own operating costs. Investors should monitor whether the ongoing clinical validation efforts can eventually translate into milestone payments that might stabilize this negative trend.
According to recent SEC filings, working capital changes have been highly erratic, swinging from a $1.3M inflow in 2025Q2 to a $415K outflow in 2025Q4, which suggests that the company's cash position is heavily dependent on the timing of client payments and project-related payables.
This volatility in working capital highlights the transactional nature of the company's revenue, where cash inflows are tied to specific project milestones rather than a steady operational cycle. Such fluctuations may complicate short-term liquidity management, especially given the company's limited cash reserves.
Based on the reported figures, stock-based compensation consistently adds back hundreds of thousands of dollars to the cash flow statement each quarter, which suggests that the company is utilizing equity to preserve cash while simultaneously diluting shareholders to fund its ongoing research and development activities.
While SBC is a non-cash expense, its consistent presence indicates that the company is effectively paying for talent with equity rather than cash. This practice may be necessary for survival, but it warrants further investigation into the long-term impact on share count and the true cost of operations.
Quick answers to the most common questions about buying DYAI stock.
Dyadic International, Inc. (DYAI) generated $-5.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Dyadic International, Inc. (DYAI) reported negative free cash flow of $5.7M in 2025, indicating capital requirements exceeded cash from operations.
Dyadic International, Inc. (DYAI) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.